SCM
OM icon

Soleus Capital Management’s Outset Medical OM Stock Holding History

Soleus Capital Management’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,613
Closed -$1.03M – 85
2022
Q2 		$1.03M Buy
+4,613
New +$1.98M 0.16% 68

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Soleus Capital Management's OM Position: Q3 2022 in Review

Soleus Capital Management sold out of Outset Medical (OM) in Q3 2022, closing a stake of 4,613 shares — an estimated $1.03M sold.

Soleus Capital Management first reported a position in OM in Q2 2022 and held it in 1 quarter. The position peaked at $1.03M in Q2 2022. 138 funds tracked by Wall St. Rank hold OM as of Q3 2022.

  • Soleus Capital Management reported no remaining Outset Medical position as of Q3 2022 after selling out during the quarter.
  • Soleus Capital Management sold 4,613 Outset Medical shares in Q3 2022, an estimated $1.03M.
  • Soleus Capital Management first reported a position in Outset Medical in Q2 2022 and held it in 1 quarter.
  • Soleus Capital Management's Outset Medical position peaked at $1.03M in Q2 2022.
  • 138 funds tracked by Wall St. Rank held Outset Medical as of Q3 2022.

Based on Soleus Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.